Blood Glucose Meter Accuracy Problems Acknowledged By FDA, Industry And Clinicians
This article was originally published in The Gray Sheet
Executive Summary
Certain 510(k)-cleared blood glucose meters do not perform at the regulatory standards for which they were cleared after they hit the market, stakeholders agree. FDA is working on the matter, but no clear plan of action was laid out at a Diabetes Technology Society meeting last week.
You may also be interested in...
FDA Catches Heat For Plans To Raise Standards For Hospital Glucose Meters
An FDA draft guidance issued earlier this year on hospital glucose meters has attracted an unusual amount of attention, including criticism from clinicians, companies and others who worry it could cut off access to point-of-care glucose testing in patient cases where it is needed
FDA Catches Heat For Plans To Raise Standards For Hospital Glucose Meters
An FDA draft guidance issued earlier this year on hospital glucose meters has attracted an unusual amount of attention, including criticism from clinicians, companies and others who worry it could cut off access to point-of-care glucose testing in patient cases where it is needed. The agency says it is taking appropriate measures to address a safety issue, and that some of the criticism is misdirected.
FDA Guidances Aim For Better Accuracy In OTC, Professional Glucose Meters
The agency for the first time issued distinct guidance documents for blood glucose meters used in professional settings and those issued over-the-counter for self-monitoring tests by lay-people. FDA is collecting comments on draft versions of the guidelines.